Martinrea International (TSE:MRE – Get Free Report) had its price objective cut by equities researchers at TD Securities from C$19.00 to C$18.00 in a report released on Monday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ price target would suggest a potential upside of 58.03% from the stock’s current price.
Separately, BMO Capital Markets dropped their price objective on Martinrea International from C$17.00 to C$15.00 in a report on Wednesday, August 7th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of C$17.64.
Read Our Latest Analysis on MRE
Martinrea International Trading Down 0.5 %
Martinrea International (TSE:MRE – Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported C$0.58 EPS for the quarter, missing analysts’ consensus estimates of C$0.61 by C($0.03). Martinrea International had a return on equity of 9.43% and a net margin of 2.65%. The firm had revenue of C$1.30 billion for the quarter, compared to analyst estimates of C$1.33 billion. As a group, research analysts expect that Martinrea International will post 2.5511983 EPS for the current fiscal year.
Martinrea International Company Profile
Martinrea International Inc engages in the design, development, and manufacturing of engineered, value-added lightweight structures and propulsion systems worldwide. It offers lightweight structure products, including knuckles/control arms/links; subframes integral/fabricated products; complex assemblies; body structures; exterior trims; and trailer hitches.
Further Reading
- Five stocks we like better than Martinrea International
- Buy P&G Now, Before It Sets A New All-Time High
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Following Congress Stock Trades
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is a Special Dividend?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Martinrea International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Martinrea International and related companies with MarketBeat.com's FREE daily email newsletter.